, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Scott Haake
Last active: 3/3/2020

  1. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK (2012) Eur Urol 61(2): 258-68
    › Primary publication · 22030119 (PubMed) · PMC3244546 (PubMed Central)
  2. Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms. Van De Water TR, Abi Hachem RN, Dinh CT, Bas E, Haake SM, Hoosien G, Vivero R, Chan S, He J, Eshraghi AA, Angeli SI, Telischi FF, Balkany TJ (2010) Cochlear Implants Int : 42-55
    › Primary publication · 21756583 (PubMed)
  3. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Haake SM, Dinh CT, Chen S, Eshraghi AA, Van De Water TR (2009) Hear Res 255(1-2): 22-32
    › Primary publication · 19442713 (PubMed)
  4. Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes. Dinh CT, Haake S, Chen S, Hoang K, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR (2008) Neuroscience 157(2): 405-13
    › Primary publication · 18838114 (PubMed)
  5. Biopolymer-released dexamethasone prevents tumor necrosis factor alpha-induced loss of auditory hair cells in vitro: implications toward the development of a drug-eluting cochlear implant electrode array. Dinh C, Hoang K, Haake S, Chen S, Angeli S, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR (2008) Otol Neurotol 29(7): 1012-9
    › Primary publication · 18818545 (PubMed)